Abstract: The present disclosure relates to methods of treating heat shock factor 1 (HSF1)-related diseases such as cancer, autoimmune and viral diseases, using a therapeutically effective amount of a RNAi agent to HSF.
Type:
Application
Filed:
August 30, 2012
Publication date:
February 4, 2016
Applicant:
Arrowhead Research Corportation
Inventors:
Jinyun CHEN, Kalyani GAMPA, Dieter HUESKEN, Frank STEGMEIER, Mark STUMP, Chandra VARGEESE, Jan WEILER, Wenlai ZHOU